Skip to content
Teethgrinder – Lifestyle
Author:
Myosin Therapeutics Inc.
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly Diagnosed Glioblastoma
May 19, 2026
Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial
March 24, 2026
Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences
March 9, 2026